186 related articles for article (PubMed ID: 12752285)
1. Radical lymph node dissection for melanoma.
Serpell JW; Carne PW; Bailey M
ANZ J Surg; 2003 May; 73(5):294-9. PubMed ID: 12752285
[TBL] [Abstract][Full Text] [Related]
2. [Surgical technique and postoperative morbidity following radical inguinal/iliacal lymph node dissection--a prospective study in 67 patients with malignant melanoma metastatic to the groin].
Mall JW; Reetz C; Koplin G; Schäfer-Hesterberg G; Voit C; Neuss H
Zentralbl Chir; 2009 Sep; 134(5):437-42. PubMed ID: 19757344
[TBL] [Abstract][Full Text] [Related]
3. [Complication of radical lymph node dissection following sentinel lymph node biopsy in patients with melanoma].
Litrowski N; Duval Modeste AB; Coquerel D; Courville P; Milliez PY; Joly P
Ann Dermatol Venereol; 2013; 140(6-7):425-30. PubMed ID: 23773739
[TBL] [Abstract][Full Text] [Related]
4. Inguinal lymphadenectomy for stage III melanoma: a comparative study of two surgical approaches at the onset of lymphoedema.
Bertheuil N; Sulpice L; Levi Sandri GB; Lavoué V; Watier E; Meunier B
Eur J Surg Oncol; 2015 Feb; 41(2):215-9. PubMed ID: 25524886
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial.
Burmeister BH; Henderson MA; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF
Lancet Oncol; 2012 Jun; 13(6):589-97. PubMed ID: 22575589
[TBL] [Abstract][Full Text] [Related]
6. Lymph node dissection in patients with malignant melanoma is associated with high risk of morbidity.
Ul-Mulk J; Hölmich LR
Dan Med J; 2012 Jun; 59(6):A4441. PubMed ID: 22677239
[TBL] [Abstract][Full Text] [Related]
7. Morbidity and oncologic outcome after saphenous vein-sparing inguinal lymphadenectomy in melanoma patients.
Baur J; Mathe K; Gesierich A; Weyandt G; Wiegering A; Germer CT; Gasser M; Pelz JOW
World J Surg Oncol; 2017 May; 15(1):99. PubMed ID: 28490340
[TBL] [Abstract][Full Text] [Related]
8. Oncologic outcomes of patients undergoing videoscopic inguinal lymphadenectomy for metastatic melanoma.
Martin BM; Etra JW; Russell MC; Rizzo M; Kooby DA; Staley CA; Master VA; Delman KA
J Am Coll Surg; 2014 Apr; 218(4):620-6. PubMed ID: 24560569
[TBL] [Abstract][Full Text] [Related]
9. Patterns of recurrence in patients with melanoma after radical lymph node dissection.
Nathansohn N; Schachter J; Gutman H
Arch Surg; 2005 Dec; 140(12):1172-7. PubMed ID: 16365238
[TBL] [Abstract][Full Text] [Related]
10. Limiting the morbidity of inguinal lymphadenectomy for metastatic melanoma.
Sarnaik AA; Puleo CA; Zager JS; Sondak VK
Cancer Control; 2009 Jul; 16(3):240-7. PubMed ID: 19556964
[TBL] [Abstract][Full Text] [Related]
11. Minimally invasive inguinal lymph node dissection (MILND) for melanoma: experience from two academic centers.
Abbott AM; Grotz TE; Rueth NM; Hernandez Irizarry RC; Tuttle TM; Jakub JW
Ann Surg Oncol; 2013 Jan; 20(1):340-5. PubMed ID: 22875645
[TBL] [Abstract][Full Text] [Related]
12. Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy.
Lee RJ; Gibbs JF; Proulx GM; Kollmorgen DR; Jia C; Kraybill WG
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):467-74. PubMed ID: 10661355
[TBL] [Abstract][Full Text] [Related]
13. Impact of extended lymphadenectomy on morbidity and regional recurrence-free survival in melanoma patients.
Baur J; Mathe K; Gesierich A; Weyandt G; Wiegering A; Germer CT; Pelz JOW
J Dermatolog Treat; 2018 Aug; 29(5):515-521. PubMed ID: 29098910
[TBL] [Abstract][Full Text] [Related]
14. Complications following completion lymphadenectomy versus therapeutic lymphadenectomy for melanoma - A systematic review of the literature.
Moody JA; Botham SJ; Dahill KE; Wallace DL; Hardwicke JT
Eur J Surg Oncol; 2017 Sep; 43(9):1760-1767. PubMed ID: 28756017
[TBL] [Abstract][Full Text] [Related]
15. Morbidity and Outcomes Following Axillary Lymphadenectomy for Melanoma: Weighing the Risk of Surgery in the Era of MSLT-II.
Postlewait LM; Farley CR; Seamens AM; Le N; Rizzo M; Russell MC; Lowe MC; Delman KA
Ann Surg Oncol; 2018 Feb; 25(2):465-470. PubMed ID: 29159743
[TBL] [Abstract][Full Text] [Related]
16. Outcomes following therapeutic lymphadenectomy for Stage III malignant melanoma in a single unit.
Jayakar R; Yassaie E; Adams C
N Z Med J; 2018 May; 131(1474):51-59. PubMed ID: 29723179
[TBL] [Abstract][Full Text] [Related]
17. Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy.
Sabel MS; Griffith KA; Arora A; Shargorodsky J; Blazer DG; Rees R; Wong SL; Cimmino VM; Chang AE
Surgery; 2007 Jun; 141(6):728-35. PubMed ID: 17560249
[TBL] [Abstract][Full Text] [Related]
18. Addition of an iliac/obturator lymph node dissection does not improve nodal recurrence or survival in melanoma.
Egger ME; Brown RE; Roach BA; Quillo AR; Martin RC; Scoggins CR; Stromberg AJ; McMasters KM
J Am Coll Surg; 2014 Jul; 219(1):101-8. PubMed ID: 24726566
[TBL] [Abstract][Full Text] [Related]
19. Quantity-guided drain management reduces seroma formation and wound infections after radical lymph node dissection: results of a comparative observational study of 374 melanoma patients.
Koplin G; Mall JW; Raue W; Böhm S; Hoeller U; Haase O
Acta Chir Belg; 2017 Aug; 117(4):238-244. PubMed ID: 28274179
[TBL] [Abstract][Full Text] [Related]
20. Robotic inguinal lymph node dissection for melanoma: a novel approach to a complicated problem.
Hyde GA; Jung NL; Valle AA; Bhattacharya SD; Keel CE
J Robot Surg; 2018 Dec; 12(4):745-748. PubMed ID: 29307097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
